Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

QIAGEN N.V. (QGEN) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

QIAGEN N.V. (QGEN), most recent 12 months reported: revenue $2.09B, net income $424.88M, free cash flow $453.28M. Latest balance sheet on file: liquid cash $1.1B, total debt $1.65B, net cash -$555.51M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): BIOGEN INC. · NEUROCRINE BIOSCIENCES INC · Exelixis Inc · Moderna, Inc. · HALOZYME THERAPEUTICS, INC. · BIO-TECHNE Corp · BIOCRYST PHARMACEUTICALS, INC. · REPLIGEN CORP

Stock screener

Watchlist